Skip to main content

Table 1 Characteristics of 11 reported patients with concomitant HIV and AIHa

From: Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature

Case reports Patient age (years)/gender Onset CD4b/CD4c VLb/VLc AIH score Outcome Other AI diseases ART
German et al. [2] 38d/man Chronic 216/384 81,000/< 50 Probable Excellent Vetilligo Yes
Coriat and Podevin [7] 48/woman Acute 250 Undetectable Probable Died None Yes
Puius et al. [3] 29/man Chronic 259/174 7122/27,732 Probable Excellent None Yes
  45d/woman Chronic 253/297 8687/< 50 Probable Excellent DILS Yes
  65/woman Acute 200/922 Undetectable/< 75 Definite Excellent None Yes
O'Leary et al. [4] 44d/woman Chronic 269/526 4927/< 50 Definite Excellent Grave's disease Yes
Wan et al. [5] 56/man Chronic 331/NA 232,734/NA Probable Died None  
  54/man Chronic 357/213 5104/NA Probable Probable Cirrhosis Yes
  55/woman Chronic 174/NA < 50/NA Probable Probable Poor Yes
  49/woman Acute 286/NA 69,318/NA Definite Definite Died Yes
Our patient 42d/woman Acute 157/232 120,000/< 50 Definite Excellent SLE Yes
  1. aTwo patients are not included because of lack of complete clinical data. HIV = human immunodeficiency virus; AIH = autoimmune hepatitis; AI, autoimmune; ART = antiretroviral treatment; VL = viral load; DILS = diffuse infiltrative lymphocytic syndrome; SLE = systemic lupus erythematosus; bprior to initiating highly active antiretroviral treatment (HAART); cafter initiating HAART; dpatients with significant viral suppression on HAART who developed AIH.